HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thierry Levade Selected Research

Pyrrolidines

10/2020Concise asymmetric synthesis of new enantiomeric C-alkyl pyrrolidines acting as pharmacological chaperones against Gaucher disease.
1/2019Selective Targeting of the Interconversion between Glucosylceramide and Ceramide by Scaffold Tailoring of Iminosugar Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thierry Levade Research Topics

Disease

34Neoplasms (Cancer)
10/2021 - 05/2003
22Melanoma (Melanoma, Malignant)
01/2021 - 06/2003
13Farber Lipogranulomatosis
01/2020 - 11/2008
7Gaucher Disease (Gaucher's Disease)
10/2020 - 10/2012
5Lysosomal Storage Diseases (Lysosomal Storage Disease)
10/2019 - 09/2009
5Starvation
11/2011 - 03/2006
4Inflammation (Inflammations)
01/2022 - 11/2009
4Inborn Genetic Diseases (Disease, Hereditary)
01/2015 - 05/2004
3Infections
02/2016 - 01/2009
3Nervous System Diseases (Neurological Disorders)
08/2015 - 09/2009
3Leukemia
04/2012 - 01/2011
3Heart Failure
09/2007 - 01/2004
2Ataxia (Dyssynergia)
01/2022 - 11/2006
2Mucopolysaccharidoses
01/2022 - 01/2018
2Niemann-Pick Diseases (Niemann Pick Disease)
10/2021 - 01/2011
2Skin Neoplasms (Skin Cancer)
11/2020 - 01/2019
2Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
01/2017 - 09/2009
2Fabry Disease (Fabry's Disease)
01/2017 - 06/2009
2Refsum Disease (Refsum's Disease)
01/2015 - 11/2006
2Obesity
08/2014 - 02/2012
2Insulin Resistance
04/2013 - 02/2012
2Weight Loss (Weight Reduction)
02/2013 - 11/2009
2Alcoholic Fatty Liver
02/2013 - 11/2009
2Necrosis
02/2013 - 12/2002
2Infarction (Infarctions)
10/2012 - 09/2007
2Lymphoid Leukemia
03/2011 - 01/2011
2beta-Mannosidosis (beta-Mannosidase Deficiency)
09/2009 - 01/2009
1Non-alcoholic Fatty Liver Disease
01/2022
1Mucopolysaccharidosis IV (Morquio Syndrome)
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Type B Niemann-Pick Disease
01/2021
1Nevus (Nevi)
11/2020

Drug/Important Bio-Agent (IBA)

29CeramidesIBA
10/2021 - 06/2003
28SphingolipidsIBA
11/2020 - 12/2002
17EnzymesIBA
01/2021 - 05/2003
14Acid CeramidaseIBA
01/2020 - 04/2007
8LipidsIBA
01/2022 - 02/2009
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2019 - 12/2002
7Proteins (Proteins, Gene)FDA Link
01/2018 - 05/2004
6Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
01/2021 - 01/2004
6sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
02/2020 - 12/2009
4SphingomyelinsIBA
10/2021 - 05/2012
4Glucosylceramidase (Glucocerebrosidase)IBA
02/2020 - 06/2016
4SphingosineIBA
02/2020 - 05/2003
4Glucosylceramides (Glucocerebrosides)IBA
02/2020 - 05/2012
4ceramide glucosyltransferaseIBA
02/2020 - 06/2003
4sphingosine kinaseIBA
01/2020 - 09/2005
4AntibodiesIBA
11/2019 - 11/2002
4CytokinesIBA
01/2017 - 01/2009
3Choline (Choline Chloride)IBA
01/2022 - 11/2009
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2017
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 11/2009
3GangliosidesIBA
10/2019 - 11/2011
3phosphatidylcholine-ceramide phosphocholine transferaseIBA
01/2019 - 05/2012
3Lysergic Acid Diethylamide (LSD)IBA
01/2018 - 11/2008
3Fas Ligand Protein (Fas Ligand)IBA
01/2017 - 04/2009
3CaspasesIBA
01/2017 - 11/2002
3HydrolasesIBA
06/2016 - 12/2004
3CholesterolIBA
01/2014 - 09/2009
3Triglycerides (Triacylglycerol)IBA
02/2013 - 11/2009
3LigandsIBA
03/2011 - 01/2003
2Tumor Necrosis Factor InhibitorsIBA
01/2021 - 11/2019
2Infliximab (Remicade)FDA Link
01/2021 - 11/2019
2Fatty Acids (Saturated Fatty Acids)IBA
10/2020 - 02/2012
2PyrrolidinesIBA
10/2020 - 01/2019
2Immune Checkpoint InhibitorsIBA
01/2020 - 11/2019
2AcidsIBA
02/2017 - 01/2004
2Caspase 9IBA
01/2017 - 04/2012
2Biological ProductsIBA
01/2017 - 12/2006
2Phytanic AcidIBA
01/2015 - 11/2006
2CeramidasesIBA
08/2014 - 08/2011
2Methionine (L-Methionine)FDA Link
02/2013 - 11/2009
2GlycosphingolipidsIBA
02/2013 - 09/2009
2Alanine Transaminase (SGPT)IBA
02/2013 - 11/2009
2Photosensitizing Agents (Photosensitizers)IBA
03/2011 - 01/2011
2Plant LectinsIBA
03/2011 - 01/2011
2PorphyrinsIBA
03/2011 - 01/2011
2AntigensIBA
03/2011 - 01/2011
25- (4- (5- carboxy- 1- butoxy)phenyl)- 10,15,20- tris(4- N- methyl)pyridiniumylporphyrinIBA
03/2011 - 01/2011
2Polysaccharides (Glycans)IBA
03/2011 - 01/2011
2LyasesIBA
04/2010 - 12/2009
2beta-MannosidaseIBA
09/2009 - 01/2009
2alpha-Galactosidase (Beano)IBA
06/2009 - 01/2006
2Beclin-1IBA
05/2009 - 03/2006
1Pharmaceutical PreparationsIBA
01/2022
1Drinking WaterIBA
01/2022
1GalactosidasesIBA
01/2022
1FructoseIBA
01/2022
1Carbon MonoxideIBA
10/2021
1Phosphorylcholine (Phosphocholine)IBA
10/2021
1NivolumabIBA
01/2021
1IpilimumabIBA
01/2021
1Interleukin-12 (IL 12)IBA
01/2021
1Microphthalmia-Associated Transcription FactorIBA
11/2020
1Monophenol Monooxygenase (Tyrosinase)IBA
11/2020

Therapy/Procedure

11Therapeutics
01/2021 - 04/2006
6Drug Therapy (Chemotherapy)
02/2020 - 04/2007
4Immunotherapy
11/2019 - 10/2018
2Photochemotherapy (Photodynamic Therapy)
03/2011 - 01/2011
1Lasers (Laser)
01/2021